Molecular Pharming - Recent Progress in Manufacturing Medicines in Plants
21 Sep 2012 - 21 Sep 2012 - London, UK
Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.
This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.
This event has CPD accreditation and will have a troubleshooting panel session.
On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event.